Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Prodrug of platelet gpIIb/IIIa receptor antagonist with excellent intranasal antithrombotic efficacy

Dec. 9, 1998

Australian university scientists design new diflunisal esters with improved characteristics

Dec. 8, 1998

Centocor will market Retavase exclusively in the U.S. starting in January

Dec. 4, 1998

Pharming and Gem to codevelop human lactoferrin (GPX-400) to neutralize heparin

Dec. 4, 1998

rNAPc2 enters phase II trials in U.S. and Europe

Dec. 3, 1998

First clinical trial of human gene therapy for hemophilia begins

Dec. 3, 1998

U.S. patent covers transgenically produced rhATIII

Dec. 3, 1998

Microbix and Gensia Sicor terminate licensing agreement

Dec. 2, 1998

Preclinical studies of XV-454 support further testing of novel fibrinogen antagonist

Dec. 1, 1998

Searle revises OPUS-TIMI 16 trial evaluating orbofiban acetate

Nov. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...